Feed ADTX
AD

Aditxt, Inc. ADTX · OTC

$0.00 -33.33% (-$0.00)

Market cap
$598.8K
Enterprise value
$4.56M
P/E
-
Forward P/E
-
PEG
-
P/S
41.8x
P/FCF
-
EV/EBITDA
-
ROIC
-406.3%
Gross margin
19.9%
Net margin
-362,386.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
0.93
Free float
0.0%

About the company

Aditxt, Inc. (ADTX) is a biotechnology company specializing in the development of innovative therapeutic and diagnostic technologies in the fields of immunology and biomedicine. The company focuses on developing products that can enhance patients' immune systems and improve their health. Aditxt develops diagnostic tools that allow for precise monitoring of immune responses and patients' health status. With the growing emphasis on personalized medicine and advanced diagnostic technologies, Aditxt, Inc. has the potential for sustained growth. Aditxt, Inc. (ADTX) shares might be an interesting choice for investors seeking involvement in the biotechnology and innovative diagnostic therapies industry.

Sector

Healthcare

Industry

Biotechnology

CEO

Jeffrey Busch

Employees

26

Headquarters

Mountain View

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy